Atea Share Price

Atea Share Price

NASDAQ: AVIR | Small Cap | Healthcare
$3.98
+$0.06 (1.40%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Atea Stock Performance

Open
$3.90
Prev. Close
$3.92
Circuit Range
N/A
Day Range
$3.90 - $4.08
Year Range
$2.93 - $6.43
Volume
20,327
Average Traded
$3.98

Atea Share Price Today

As of 21 November 2026, Atea Pharmaceuticals, Inc.'s share price is $3.98. The stock opened at $3.90, compared to its previous close of $3.92. During today's trading session, Atea Pharmaceuticals, Inc.'s share price traded between $3.90 and $4.08, with an average price of $3.99. Over the past 52 weeks, the stock has recorded a high of $6.43 and a low of $2.93. In terms of performance, Atea Pharmaceuticals, Inc.'s share price has declined by 14.50% over the last six months and is up 28.80% on a year-on-year basis.

Atea Share Price Chart

Line chart of the Atea price trend over the selected period. The price rose overall, ranging from 3.83 to 4.02, ending at 3.98.
$3.90$4.08
L
Show Current Price
H

Atea Stock Fundamentals & Key Indicators

Market Cap
$324.35M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.94
Revenue (TTM)
$0.00
Return On Equity (TTM)
-88.46%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
28.33%

Atea Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$44.87-$45.44-$32.93-$32.16
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-1.27%27.53%2.34%

Atea Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$115.91-$135.96-$168.39-$158.35
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-17.30%-23.85%5.96%

Atea Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets4.232.314.515.79
Current Assets310.99462.36590.46660.92
Total Assets315.22464.67594.97666.71
Non Current Liabilities0.07.27.47.66
Current Liabilities39.7818.632.3818.48
Total Liabilities39.7825.839.7826.14
Shareholders' Equity275.43438.87555.19640.57

Atea Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-132.03-135.5-85.4-120.98
Investing188.7956.1140.3-455.41
Financing-25.750.270.260.37

About Atea

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.

Atea Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$4.23
$3.96
-3.27%
Oct 2026
$5.11
$4.09
-21.42%
Sep 2026
$5.38
$5.21
-4.40%
Aug 2026
$4.70
$5.45
+16.08%
Jul 2026
$4.69
$4.70
+0.97%
Jun 2026
$4.55
$4.65
-0.11%
May 2026
$5.41
$4.66
-15.59%
Apr 2026
$5.43
$5.51
+2.60%
Mar 2026
$4.71
$5.38
+14.61%
Feb 2026
$4.18
$4.69
+10.61%
Jan 2026
$3.52
$4.24
+18.27%
Dec 2025
$3.05
$3.58
+16.02%

Atea Share Price FAQs